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Abstract: Ischemia, referring to reduction and restriction of perfusion to myocardial tissue which involves coro-
nary artery through the formation of misplaced clots and thrombosis, is one of the most important cardiovascular 
diseases. Plant-based compounds help to improve or prevent disease by affecting the factors involved in the dis-
ease. This review was conducted to report the medicinal plants and factors effective in cardiac ischemia-
reperfusion (I/R) injury to supplement the knowledge about this disease and its prevention and treatment using 
certain medicinal plants and their active compounds. For this purpose, medicinal plants and their potential anti-
oxidant activities, effects on lipid levels and plaque formation, atherosclerosis and development of cardiovascular 
diseases and ischemia were reviewed.  
Methods: To conduct this review, relevant articles published between 1983 and 2018 were retrieved from the 
Google Scholar, PubMed, Scientific Information Database, Web of Science, and Scopus using search terms anti-
oxidant, ischemia, reperfusion, heart, infarct, inflammation, cholesterol and medicinal plants. Then, the eligible 
articles were reviewed. 
Results: The active compounds of plants, including phenolic compounds, flavonoids, and antioxidant compounds, 
can be effective on certain pathogenic factors particularly in decreasing cholesterol and blood pressure, prevent-
ing an increase in free radicals and ultimately reducing blood clots and vascular resistance to reduce and prevent 
ischemic disease and its harmful effects. 
Conclusion: Medicinal plants discussed in this article seem to be able to prevent cardiac damage and the disease 
progression via affecting the factors that are involved in ischemia. 
Keywords: Cardiac ischemia, antioxidant, blood, cholesterol, infarction. 
1. INTRODUCTION 
 Cardiovascular diseases (CVDs) may have various certain 
causes such as hypertension, hypoxia, elevated total cholesterol, 
cholesterol, and low-density lipoprotein (LDL), decreased serum 
high-density lipoprotein (HDL) level, diabetes mellitus, increasing 
age, oxidative stress, and inflammation [1-5]. As one of the vital 
organs of the body, the heart can be exposed to ischemia that causes 
tissue injury and dysfunction [6]. Myocardial infarction is the most 
common cause of heart failure that occurs mainly due to a sudden 
reduction in coronary circulation following thrombolytic obstruc-
tion in one of the coronary arteries already constricted due to athe-
rosclerosis. The incidence of MI is associated with the ST segment 
elevation in the electrocardiogram compared to the isoelectric line. 
MI is associated with certain changes such as cardiomyocytes hy-
pertrophy, myocardial arrhythmia, systolic and diastolic left ven-
tricular dysfunction, decreased contractility of the left ventricle, 
increased fibrosis and apoptosis, and reduced capillary density [7]. 
 Physicians seek to find the safest possible pattern in cardiac 
ischemia-reperfusion (I/R) so that contractile function can be 
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restored in the shortest possible time and at the same time irreversi-
ble damage to muscle cells can be prevented. Unfortunately, reper-
fusion in the ischemic heart itself causes tissue injury referred to as 
I/R injury. Reperfusion can lead to dangerous and sometimes fatal 
ventricular arrhythmias, such as tachycardia, ventricular fibrillation, 
and decreased contractility. Immediately after reperfusion, necrosis 
and cell death begin, and if perfusion persists, further apoptosis and 
necrosis are continued. This may also result in other complications 
such as renal impairment [8-11]. Free radicals can lead to cell death 
(via apoptotic pathways) and therefore left ventricular dysfunction 
through damaging lysosomes, enzyme membrane, and DNA as well 
as increasing intracellular calcium [12, 13].  
 In addition, cardiac muscle cells have two enzymatic and 
nonenzymatic mechanisms to balance oxidative stress. Superoxide 
dismutase (SOD), catalase (CAT), and glutathione peroxidase 
(GPX) are the most important antioxidant enzymes. In response to 
MI, oxidative stress is associated with decreased antioxidant en-
zymes [14]. With alteplase, streplase, urokinase, and streptokinase, 
thrombolytic therapy is used to treat I/R injuries [15-17]. But their 
side effects such as generalized leticine, effects on misplaced plate-
let nails, and allergic reactions have limited their use. Considering 
the increasing prevalence of CVDs and decreasing the age at the 
incidence of these diseases, it is essential to seek out drugs and 
medicinal plants that can be used routinely in the diet, help control 
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and prevent clotting, and also reduce the risk factors for heart dis-
eases and ischemia. Although synthetic drugs have desirable ef-
fects, they lead to long-term side effects that, in some cases, are 
transmitted to the next generation, while the side effects of herbal 
medicines are generally fewer. This has led to an increase in the 
tendency to use herbal medicines over the last decade. Researches 
have also demonstrated the positive effects of herbal medicines on 
cardiac ischemia. Besides, it has been reported that use of flavon-
oids and antioxidant compounds is associated with decreased risk of 
coronary heart disease, atherosclerosis and MI [18, 19]. 
 This review was conducted to report the medicinal plants and 
factors effective in I/R injury, to supplement the knowledge about 
this disease and its prevention and treatment using certain medicinal 
plants and their active compounds. For this purpose, medicinal 
plants and their potential antioxidant effects, effects on lipid levels 
and plaque formation, atherosclerosis and development of cardio-
vascular diseases and ischemia were reviewed. 
2. MATERIALS AND METHODS 
 To conduct this review, relevant articles published between 
1983 and 2018 were retrieved from the Information Sciences Insti-
tute (ISI), PubMed, Scientific Information Database (SID), and 
Scopus using search terms antioxidant, ischemia, reperfusion, heart, 
infarct, inflammation, cholesterol and medicinal plants. Then, the 
eligible articles were reviewed. 
3. RESULTS 
3.1. Ischemia Pathology 
 MI and heart arrhythmia are two fatal complications of coro-
nary artery disease [20]. MI refers to the death of myocardial cells 
due to long-term ischemia. Ischemia refers to the reduction and 
restriction of perfusion to myocardial tissue [21]. Indeed, ischemia 
is characterized by lack of oxygen and inadequate removal of the 
metabolites due to reduced perfusion. It usually leads to several 
biochemical, metabolic, functional, and morphological changes. 
Formation of tissue metabolites, particularly organic phosphates, 
decreases contraction intensity through reducing the sensitivity of 
myofilaments to calcium that can lead to death. Such conditions, 
referred to as ischemic storage, may lead to MI and unstable tho-
racic angina [22]. 
 In response to ischemia, myocardium causes shift of aerobic 
metabolism toward anaerobic mechanism and reduction in heart-
beats and the amount of myocyte shortening during systolic con-
traction through decreasing oxygen consumption, and therefore 
energy reserves decrease. In addition, the work of the heart requires 
the maintenance of energy from the oxidative phosphorylation path-
ways in the mitochondria that is much greater than the total content 
of its ATP, which is the reason for cardiac ischemia-reperfusion 
injury . Clearly, immediately after blockage of the coronary artery 
or cell death, the heart loses its function within a few hours [23]. 
 Ionic disturbances and activation of intracellular enzymes can 
also cause certain damaging changes such as the effects of prote-
ases on cellular skeletal proteins and those of lipases on the mem-
brane phospholipid components. Lipids also provide a good sub-
strate to form oxygen free radicals through forming fatty acids, 
which eventually kills the cells by destroying the cell membrane 
[24]. 
 Over the past two decades, reperfusion in ischemic myocardium 
has been considered as one of the most important treatments [25]. 
However, it can cause tissue injury [26]. These injuries (namely I/R 
injuries) are widely varied and lead to life-threatening and some-
times fatal ventricular arrhythmias such as tachycardia, ventricular 
fibrillation, myocyte apoptosis and necrosis, and coronary artery 
endothelial injury. Due to this injury, the coronary artery response 
to vasodilators declines; the endothelial injury also causes activa-
tion of the platelets; and the leukocytes adhere to the endothelium 
and release cytotoxic and chemotoxic agents such as leukotrienes, 
proteases, cytokines, and oxygen free radicals in the myocardium 
perfused area through the neutrophils migration to this area, and 
therefore tissue injury is exacerbated [27]. 
 In response to MI, oxidative stress accompanied by the cell 
damage causes an increase in cardiac enzymes and decrease in anti-
oxidant enzymes such as SOD, CAT, and GPX [14]. 
 Pathophysiological mechanisms include release of oxygen free 
radicals [28], accumulation of calcium [29], activation of renin-
angiotensin system [30], activation of neutrophils and inflammation 
[31], accumulation of the platelets and products released from them 
such as thromboxane A2, and activation of the complement system 
[27]. Besides, misplaced clots and thromboembolism are developed 
through hemostatic disorders. The thrombosis developed in the 
circulation due to hemostatic system defects causes arterial block-
age, atherothrombotic diseases, MI, stroke, and ultimately death 
[15]. 
3.2. Epidemiology 
 CVDs are the most common causes of mortality worldwide. 
According to the WHO report, annually 12000000 people world-
wide die due to CVDs. The prevalence of non-communicable dis-
eases is rising in developing countries including Iran, and the bur-
den due to CVDs and associated outcomes is significant such that 
CVDs represent the leading cause of death. Although the available 
data are not reliable, approximately 300 people die in Iran each day, 
according to the Ministry of Health and Medical Education. The 
mortality rate due to CVDs in Iran is the fifth leading one world-
wide, and therefore Iran has one of the highest mortality rates due 
to CVDs in the world. MI is the most common cause of heart fail-
ure[32].  
 Despite the increased public awareness of the need for preven-
tion of heart disease, and the government planning for this issue, the 
number of people who refer to healthcare centers for CVDs is in-
creasing every day. Clearly, managers and officials should adopt 
appropriate viewpoints regarding the conditions of patients with 
cardiac ischemia in the community to do more efficient and accu-
rate planning.  A snapshot shows that patients with cardiac ischemia 
require special services that may not only be costly, but will also 
result in irreversible complications if their reception is delayed. It 
is, therefore, necessary for health managers and officials to have 
correct information about the frequency of this disease and required 
services as well as its epidemiological patterns [33]. 
3.3. Etiology 
 Hypertension and heart valve diseases are the underlying and 
exacerbating cause of heart failure and MI in 65.1% of the cases. 
MI refers to myocardial cell death due to the loss of circulation and 
the onset of severe and prolonged ischemia. In most cases, arterio-
sclerosis leads to MI. MI also leads to certain changes including 
cardiomyocytes hypertrophy, myocardial arrhythmia, systolic and 
diastolic left ventricular dysfunction, decreased contractility of the 
left ventricle, increased fibrosis and apoptosis, and reduced capil-
lary density [7]. Clinical and experimental works have indicated 
that arterial endothelium plays a significant role in modulating ven-
tricular dysfunctions and regenerating blood vessel in heart failure. 
In this regard, angiogenesis seems vital for blood re-supply to a 
region of the heart that is affected by hypoxia after MI [34]. 
 Angiogenesis refers to the generation of vasculatures from the 
preexisting ones that are most important to the maintenance of the 
integrity of the vessels in both the process of repairing damaged 
tissues (wound healing) and the formation of lateral vessels in re-
sponse to myocardial ischemia [35]. In its broadest sense, angio-
genesis cannot be considered a single process, but rather a compli-
cated process that is controlled by the balance between angiogenic 
and angiostatic factors. Among angiogenic factors, vascular endo-
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thelial growth factor (VEGF) is known as the most potent endothe-
lial cell-specific mitogen that causes growth, proliferation, viability, 
and migration of the endothelial cells and increase in vascular per-
meability through receptor tyrosine kinases. The presence of VEGF 
after MI is vital for cardiac angiogenesis and cardiac rescue [36]. 
Increased available nitric oxide (NO) improves many of the im-
paired cardiac processes including angiogenesis. NO, directly and 
indirectly, increases the gene expression and half-lives of the VEGF 
and reduces the amount of angiostatin and ultimately stimulates the 
process of angiogenesis [37, 38]. 
 Reviews have reported that NO contributes significantly to 
protecting the myocardial arteries and myocardium itself through 
antioxidant and anti-apoptotic properties, prevention of Ca2+ over-
load, vasodilation, and angiogenesis [36]. In this regard, inhaled 
NO has been reported to cause a decrease in the myocardial tissue 
size and improve left ventricular function after I/R through decreas-
ing the neutrophils [37].In addition, exacerbating causes such as the 
patient’s lack of adhering to drug orders, age, sex, alcohol con-
sumption, pulmonary embolism, infection, stress, and hyperthyroid-
ism should be taken into account. 
3.4. Diagnosis 
 Ischemic heart diseases are diagnosed by typical pain, changes 
in the ECG, echocardiography, and medical history. Diagnosis of 
the disease is also made by determining the levels of total choles-
terol, high-density lipoprotein, low-density lipoprotein, and triglyc-
eride, blood pressure, and body mass index, history of smoking and 
MI, the severity of angina, and the diagnosis of coronary artery 
stenosis by coronary angiography [39]. 
3.5. Treatment 
 Recent studies have demonstrated that percutaneous coronary 
intervention and thrombolytic therapy have been used in treating 
I/R injuries in clinical trials. Thrombolytic agents such as alteplase, 
streplase, urokinase, and streptokinase are also used to treat these 
patients [15, 17]. These compounds have various side effects [18, 
40, 41]. 
 Treatment with medicinal plants and their compounds has po-
tential to prevent acute coronary syndromes, cardiac and cerebral 
ischemia, or the ischemia in other tissues through inhibiting coagu-
lant, inflammatory, plaque-developing activities, and cardiac en-
zymes as well as increasing antioxidant enzymes. Regarding this 
disease, it can be said that many medicinal plants have great anti-
oxidant potential and can, therefore, play significant roles in fight-
ing free radicals [42]. 
 The positive effect of vegetarian diet is confirmed by the slow-
ing down of growth, stopping and reversibility of coronary lesions 
as well as beneficial clinical effects in reducing angina, total choles-
terol, LDL, and BMI in patients. The main aim of conducting this 
review is to study and introduce these nutritional and herbal com-
pounds with potent antioxidant and hypolipidemic effects, and pre-
ventive effects on the formation of free radicals and plaques as well 
as the development of atherosclerosis, CVDs and ischemia. 
 Table 1 summarizes the studies on the protective effects of 
medicinal plants on I/R. The botanical names, family names, used 
parts, studied concentrations, and action mechanisms of the plants 
have also been tabulated.  
4. DISCUSSION 
 In this article, the positive effects of a number of medicinal 
plants in preventing heart diseases especially I/R were reviewed. As 
already mentioned, medicinal plants and their compounds can cause 
a decrease in injuries due to cardiac ischemia through several path-
ways in heart and other organs like kidney [71, 72]. The mecha-
nisms involved include increasing oxygen supply to the heart and 
subsequently increasing cardiac contractility, lowering blood pres-
sure, decreasing cholesterol, triglyceride, and LDL as well as in-
creasing HDL, cholesterol, and apolipoprotein A, reducing lipid 
peroxidation, MDA, calcium, and prostaglandins, dilating coronary 
arteries, increasing the expression of anti-apoptotic genes, reducing 
necrosis and inflammation, myocardial infarct size, arrhythmias, 
platelet accumulation, fibrinolytic effects, clot lysis, cardiac en-
zymes creatine kinase, lactate dehydrogenase, malondialdehyde, 
and cardiac troponin I, and increasing antioxidant enzymes such as 
SOD and GPX. The most important mechanism is antioxidant ef-
fects.  
 Cardiac ischemia causes a shift of aerobic metabolism toward 
anaerobic mechanism and reduction in heartbeats and the amount of 
myocyte shortening during contraction. 
 Evidence also indicates the association of the components of 
the coagulation system (fibrinogen and factor 7) and fibrinolytic 
factors including tissue plasminogen activator and plasminogen 
activator inhibitor with heart diseases [73]. Zataria moltiflora, 
Heracleum persicum, and Curcuma domestica prevent ischemia 
through fibrinolytic and clot lysis effects [59]. 
 Following ischemia, inflammatory factors are activated, macro-
phages produce certain cytokines such as interleukin 1(IL 1) and 
tumor necrosis factor (TNF) that cause enhancement of leukocyte 
binding and platelet accumulation, and monocyte chemotactic pro-
teins cause enhancement of leukocyte function in atheromatous 
plaques. The free radicals produced from macrophages cause mus-
cle cell proliferation through oxidizing LDL. The main complica-
tions of this condition are MI and stroke [74]. Most plants intro-
duced in the present review and some other ones such as Chicho-
rium intybus and Rosa canin have been reported to contribute in 
protecting the heart or kidney against ischemia through antioxidant, 
hypolipidemic, hypotensive, anti-inflammatory, and infarct size-
reducing effects [60, 61, 75, 76]. 
 Hypolipidemia is another risk factor for atherosclerosis and 
progression of diabetes complications especially CVDs and ische-
mia [77, 78]. Investigations have demonstrated an inverse correla-
tion between using medicinal plants or polyphenol-rich foods and 
CVDs. This is related to polyphenols’ ability to prevent LDL cho-
lesterol oxidation. For example, Olea europaea, Cinamomum Spp 
and Artemisia dracunculus cause a decrease in cholesterol levels 
and lipid peroxidation as well as an increase in the antioxidant en-
zymes [56, 69, 70]. 
 In addition, beta-glucan, isolated from Hordeum vulgare, de-
creases cholesterol and LDL, increases LDH, and prevents arterio-
sclerosis and ischemia [45]. 
 In patients with heart diseases, arrhythmias are one of the most 
predisposing factors for heart failure and cardiac ischemia. The 
causes of cardiac arrhythmias are one or more sets of disorders such 
as disruption of rhythm production by the SA node, the blockage at 
different points in the pathway of impulse transfer in the heart, the 
production of abnormal impulses, and change of pacemaker loca-
tion in the cardiac conduction rhythm generating system [13]. 
 Certain medicinal plants such as Crocus sativa can reduce ar-
rhythmia and ischemic complications via blocking calcium chan-
nels, exerting anti-arrhythmic, hypolipidemic, and antioxidant ef-
fects, and inhibiting tachycardia In response to MI, oxidative stress, 
accompanied by cell damage, leads to an increase in the cardiac 
enzymes and decrease in the antioxidant enzymes such as SOD, 
GPO, and CAT [78, 79]. Lipid peroxidation on unsaturated fatty 
acids leads to the production of MDA, which can be due to the 
weakness of the antioxidant system [80, 81]. 
 In MI, total LDH levels begin to increase within 2-48 hours and 
return to normal levels 2-3 days after the incidence of MI. Troponin 
is one of the contractile proteins of muscle including heart muscle. 
Serum troponin levels are used for MI diagnosis [82]. Cardiac tro-
ponins consist of troponins T, C, and I. In MI patients, cardiac
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Table 1. Effective medicinal plants and compounds used in cardiac ischemia-reperfusion. 
Results Plant Part Used Dose Family Plant Name  No 
sativa contains different vitamins including vitamin C 
with the antioxidant property that decrease blood 
cholesterol and arterial blockage [43, 44]. 
Seed Treating male Wistar rats 
with 125 mg/kg  
Poaceae Avena sativa L 1 
Beta-glucan derived from H. vulgare decreases choles-
terol and LDL, increases LDH, and prevents arterial 
blockage and ischemia [45].  
Seed Treating male Wistar rats 
with 62.5 mg/kg 
Poaceae Hordeum vulgare  2 
Proanthocyanidins present in V. vinifera seed maintain 
hydroxyl radicals, cause a decrease in intracellular 
calcium, enhance the resistance of ische-
mia/reperfusion injuries, and decrease infarct size and 
arrhythmias [46]. 
Seed Treating male Wistar rats 
with 1, 10, and 100 mg/kg 
Vitaceae Vitis vinifera 3 
Preventing the formation of free radicals and reducing 
necrosis, the heart inflammation, and infarct [47]. 
Whole Treating male Wistar rats 
with 0.5%, 0.25%,and 125%  
Mel،٬ Honey Mel, Honey 4 
Decreasing platelet accumulation and preventing oxi-
dation of low-density lipoproteins due to their antioxi-
dant effects and preventing infarct [48, 49]. 
Leave 1 per day in human subjects Theaceae Camellia sinensis 5 
Scavenging reactive oxygen species, decreasing in-
flammation, and preventing ischemia [50]. 
Fruits Treating male Wistar rats 
with 500 mg/ml 
Rosaceae Rosa canin 6 
Significantly reducing cardiac function and exacerbat-
ing Ischemia-reperfusion injuries through activating 
proteases and changing contractile proteins, oxidizing 
pyruvate in the mitochondria, producing lactate, and 
decreasing pH [51]. 
Root Treating male Wistar rats 
with 0.03 and 0.06 mg/ml 
leguminosa Prosopis farcta 7 
Scavenging free radicals and preventing arterial block-
age, and reducing ischemia through decreasing 
malondialdehyde levels [52, 53]. 
Seed Treating male Wistar rats 
with 400 mg/ml 
Punicaceae Punica granatum 8 
Positive inotropic and chronotropic effects on the heart 
or a mechanism different from the intracellular mecha-
nism [54]. 
Flowering shoots Treating male Wistar rats 
with 1, 2, and 50 mg/ml 
Labiatae Teucrium polium 9 
Increasing antioxidant property and decreasing lipid 
peroxidation [49]. 
Aerial parts Treating male Wistar rats 
with 150 and 300. 
Portulacaceae Portulaca ol-
eracea L 
10 
Dilating coronary arteries outside the nitric oxide 
mechanism [55]. 
Leave Treating male Wistar rats 
with 5, 22, 15, 5, 7, and 30 
Umbelliferae Falcaria vulgaris 11 
Hypolipidemic, lipid peroxidation-reducing, and anti-
oxidant enzyme activity-increasing [56]. 
Leave Treating male Wistar rats 
with 50, 75, and 100  
Oleaceae Olea europaea 12 
Antiarrhythmic, tachycardia-treating, calcium-
blocking, cholesterol-reducing, and antioxidant [57, 
58] 
Flowers Dose-dependent in human 
subjects 
Iridaceae Crocus sativua 
 
13 
Fibrinolytic and clot-lysis effects and prevention of 
heart diseases and ischemia [59]. 
Leave 0.1, 0.01, and 0.001 ml adja-
cent to the clot 
Labiateae Zataria moltiflora  14 
Fibrinolytic and clot-lysis effects and prevention of 
heart diseases and ischemia [59] 
Fruits 0.1, 0.01, and 0.001 ml adja-
cent to the clot 
Umbelifera Heracleum per-
sicu 
15 
Fibrinolytic and clot-lysis effects and prevention of 
heart diseases and ischemia [59]. 
Bark 0.1, 0.01, and 0.001 ml adja-
cent to the clot 
Zingiberaceae Curcuma domes-
tica 
16 
Protecting the heart against antioxidant property, hy-
polipidemic and hypotensive effects, and decreasing 
infarct size [60, 61]. 
Leave Treating male Wistar rats 
with 1 and 3 mg/ml 
Asteraceae Chichorium inty-
bus 
17 
(Table 1) Contd.... 
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Results Plant Part Used Dose Family Plant Name  No 
Antioxidant property, antiarrhythmic effect, and de-
creasing infarct size [53].  
Leave Treating male Wistar rats 
with 10, 50, and 100 µg/ml 
Lamiaceae Marrubium cras-
sidens 
18 
Preventing production of free radicals, increasing 
glutathione peroxidase and superoxide dismutase 
through decreasing creatine kinase, lactate dehydro-
genase, and malondialdehyde and decreasing infarct 
size [62]. 
Leave Treating male Wistar rats 
with 0.1 g 
Ranuncu-
laceae 
Shen-Fu 19 
Decreasing the indices of lipid peroxidation such as 
malondialdehyde, superoxide and hydroxyl radicals, 
and tissue-protecting enzymes with antioxidant prop-
erty such as glutathione peroxidase and superoxide 
dismutase; anti-platelet accumulation property and 
prevention of heart diseases and ischemia [63, 64]. 
Leave 1% + pulverized food in male 
Wistar rats 
Alliaceae Allium ursinumon 20 
Potent antioxidant property, decreasing peroxidation 
of lipids such as malondialdehyde and decreasing 
cardiac troponin I, blood pressure, and infarct size 
[65]. 
Leave 50, 100, and 200 mg/kg Lamiaceae Melissa offici-
nalis 
21 
Decreasing the levels of cholesterol, low-density lipo-
protein, and factor 7 as well as increasing the levels of 
high-density lipoprotein cholesterol, and apolipopro-
tein A [66]. 
Aerial parts and 
seeds 
1.5 g G. tournefortii + 98.5 g 
base food for two weeks in 
white adult male rabbits 
Asteraceae 
 
Gundelia tourne-
fortii 
22 
Decreasing lipid peroxidation and superoxide and 
hydroxyl radicals and increasing antioxidative en-
zymes [67]. 
Bulbs Feeding for three months 
according to human subjects’ 
clinical needs 
Liliaceae Allium sativum 
 
23 
Antioxidant effects and scavenging radicals [68]. 
Flowers Normal diet + 150 mg/kg 
extract for 30 days in adult 
rabbits 
Hypericceae Hypericum perfo-
ratum 
24 
Fibrinolytic and clot-lysis effects and prevention of 
heart diseases and ischemia [59]. 
decreased serum lactate dehydrogenase ،٬ Troponin I  
and malondialdehyde and increased the serum super-
oxide dismutase[69].  
Bark 50,100,200 mg/kg 
adjacent to the clot, ischemia 
Lauraceae Cinamomum Spp 26 
Decreasing the levels of cholesterol, triglycerides, and 
increasing antioxidative enzymes[70] 
Oil The groups of rats selected 
for the study 
were treated orally with lo-
vastatin (10 mg/kg) and 
EOAD (15–60 mg/kg) daily 
for the two weeks.  
Asteraceae 
 
Artemisia 
dracunculus 
27 
 
 troponins T and I begin to elevate up to three hours after the inci-
dence of MI. Troponins T and I remain high for 10-12 and 7-10 
days, respectively [83, 84]. For example, Melissa officinalis and 
Allium ursinumon have potent antioxidant effects and decrease 
peroxidation of lipids such as MDA, cardiac enzyme CTnI, blood 
pressure, and infarct size [63, 65].  
 Evidence on heart and renal diseases indicate that flavonoids 
and phenolic compounds in plants have several biological effects 
including antioxidant, free radical-scavenging, anti-inflammatory, 
and anticancer activities [85-90]. Many polyphenols including 
capechin and quercetin, and ethanol exert support effects against 
vascular diseases that can be attributed to increased fibrinolytic 
activity and the expression of the proteins involved in the fibri-
nolytic system [91]. These polyphenols cause a decrease in lipid 
peroxidation and enhancement of antioxidant enzymes activities 
through their antioxidant effects [92]. In addition to affecting car-
diac ischemia positively, these antioxidant effects of the plants lead 
to optimal effects on many other diseases from which the patient 
may be suffering.  
 Altogether, medicinal plants can be effective in ischemic heart 
diseases through different mechanisms, and patients with these 
diseases are recommended to use these plants. 
CONCLUSION  
 This article reveals that there is a negative correlation between 
the use of medicinal plants, full of polyphenols having antioxidants, 
and the occurrence of heart diseases especially I/R, so that medici-
nal plants and their compounds can decrease the cardiac ischemia 
injuries through several pathways in heart and other organs like 
kidney. The mechanisms involved include dilating coronary arter-
ies, enhancement of antioxidant enzymes such as SOD and GPX, 
oxygen supply to the heart and subsequently increase in cardiac 
contractility, reduction of blood pressure, cholesterol, triglyceride, 
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cholesterol, LDL, lipid peroxidation, MDA, prostaglandins, necro-
sis, inflammation, myocardial infarct size, arrhythmias, platelet 
accumulation, fibrinolytic effects, clot lysis, cardiac enzymes as 
well as increase in HDL, and apolipoprotein A and expression of 
anti-apoptotic genes. In sum, medicinal plants are beneficial in 
ischemic heart disease through various mechanisms, and patients 
with these diseases are recommended to use them. 
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